Please tell us what you thought about today’s presentation by taking the survey below:
The treatment of schizophrenia has evolved over the past half-century primarily in the context of antipsychotic drug development. In addition to reviewing the evolution of antipsychotic treatments for schizophrenia, in this virtual live event the speakers will discuss definitions of adherence and review possible reasons for nonadherence, as well as compare evidence supporting oral and long-acting injectable antipsychotics. Lastly, the speakers will explore potential communication strategies for clinicians to assess patient adherence and discuss alternative interventions.
Martin Guerrero, MD, JD
Forensic and Geriatric Psychiatrist, El Paso, Texas
Jessie Chambers, PhD
Medical Science Liaison
Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Notifications
